1. Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia

   • Martina Quattrone
   • Alessia Di Pilla
   • Luana Fianchi

   Review Open access 30 January 2023 Pages: 1823 - 1833

2. Evaluation and validation of the prognostic value of platelet indices in patients with leukemia

   • Yuyan Li
   • Shuangge Wang
   • Tingting Zhou

   Review 09 January 2023 Pages: 1835 - 1844

   

3. Advanced micro-/nanotechnologies for exosome encapsulation and targeting in regenerative medicine

   • Hasti Tashak Golroudbari
   • Seyedeh Parnian Banikarimi
   • Hossein Ahmadi Tafti

   Review 27 January 2023 Pages: 1845 - 1866

   

4. A review of research on eligibility criteria for clinical trials

   • Qianmin Su
   • Gaoyi Cheng
   • Jihan Huang

   Review 05 January 2023 Pages: 1867 - 1879

   

5. Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells

   • Xiaoqiang Gao
   • Shi Zuo

   Review Open access 11 February 2023 Pages: 1881 - 1899

   

6. Therapeutic options in hepatocellular carcinoma: a comprehensive review

   • Diwakar Suresh
   • Akshatha N. Srinivas
   • Divya P. Kumar

   Review 13 February 2023 Pages: 1901 - 1916

   

7. RNA modification in mRNA cancer vaccines

   • Yingxue Mei
   • Xiang Wang

   Review 14 February 2023 Pages: 1917 - 1931

   

8. Prognostic value of stem-like circulating tumor cells in patients with cancer: a systematic review and meta-analysis

   • Qi Zhang
   • Defeng Kong
   • Wen Zhang

   Review 03 February 2023 Pages: 1933 - 1944

   

9. Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis

   • Nicole Hardy
   • Charan Thej Reddy Vegivinti
   • Tejo N. Musunuru

   Review 16 February 2023 Pages: 1945 - 1959

   

10. A bibliometric analysis and visualization of nonalcoholic fatty liver disease from 2012 to 2021

    • Zhipeng Li
    • Shijie Cao
    • Ning Kang

    Review 16 February 2023 Pages: 1961 - 1971

    

11. The role of FoxM1 in immune cells

    • Jinju Zheng
    • Xiaocui Bu
    • Peng Zhao

    Review 13 March 2023 Pages: 1973 - 1979

    

12. Is there a role for microbiome-based approach in common variable immunodeficiency?

    • Remo Poto
    • Gianluca laniro
    • Gilda Varricchi

    Review Open access 03 February 2023 Pages: 1981 - 1998

    

13. Correction to: Is there a role for microbiome‑based approach in common variable immunodeficiency?

    • Remo Poto
    • Gianluca Ianiro
    • Gilda Varricchi

    Correction Open access 14 March 2023 Pages: 1999 - 1999

14. Predictive value of C-reactive protein for disease severity and survival in COVID-19 patients: a systematic review and meta-analysis

    • Lihong Chi
    • Shuai Wang
    • Jianghong Luo

    Review Article 23 November 2022 Pages: 2001 - 2008

    

15. Current status and future of anti-angiogenic drugs in lung cancer

    • Xuan Yan
    • Zhangyan Zhao
    • Haicheng Tang

    Review 15 March 2023 Pages: 2009 - 2023

    

16. Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis

    • Fuxing Zhao
    • Guoshuang Shen
    • Jiuda Zhao

    Review Article 24 November 2022 Pages: 2025 - 2040

    

17. Preliminary assessment of cardiotoxicity in chimeric antigen receptor T cell therapy: a systematic review and meta-analysis

    • Minjia Guo
    • Xiaotong Wang
    • Defeng Pan

    Review 17 March 2023 Pages: 2041 - 2050

    

18. Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma

    • Qiongyue Zhang
    • Yan Huang
    • Jianhe Gan

    Original Article 24 September 2022 Pages: 2051 - 2064

    

19. Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma

    • Linping Xu
    • Hui Yang
    • Wei Li

    Original Article 28 September 2022 Pages: 2065 - 2083

    

20. Correction to: Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma

    • Linping Xu
    • Hui Yang
    • Wei Li

    Correction 31 January 2023 Pages: 2085 - 2085

21. Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis

    • Fang Qian
    • Wei Kong
    • Kai Wei

    Original Article 22 October 2022 Pages: 2087 - 2104

    

22. Systemic immune-inflammation index and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta-analysis

    • Duqiang Li
    • Xiaoyan Zhao
    • Dong Song

    Original Article 26 October 2022 Pages: 2105 - 2114

    

23. Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis

    • Jin-Cheng Tian
    • Hui Liu
    • Tao Li

    Original Article 16 November 2022 Pages: 2115 - 2129

    

24. Lower risk of hepatocellular carcinoma with tenofovir than entecavir in antiviral treatment-naïve chronic hepatitis B patients: a systematic review and meta-analysis involving 90,897 participants

    • Jinman Shao
    • Yishu Wang
    • Chunmei Lyu

    Research 17 January 2023 Pages: 2131 - 2140

    

25. Comparison of the efficacy and safety of selective internal radiotherapy and sorafenib alone or combined for hepatocellular carcinoma: a systematic review and Bayesian network meta-analysis

    • Hao Zeng
    • Chengyuan Zhou
    • Yunwei Han

    Research Open access 03 February 2023 Pages: 2141 - 2150

    

26. Hepatic vitamin D receptor expression is negatively associated with liver inflammation and fibrosis in patients with chronic HBV infection

    • Kai Yang
    • Ying Pan
    • Xian Wang

    Original Article 27 October 2022 Pages: 2151 - 2158

    

27. Chronic viral hepatitis accelerates lung function decline in smokers

    • Suh-Young Lee
    • Sun-Sin Kim
    • Heung-Woo Park

    Research 30 November 2022 Pages: 2159 - 2165

    

28. RAGE deficiency ameliorates autoimmune hepatitis involving inhibition of IL-6 production via suppressing protein Arid5a in mice

    • Xiaoxiao Li
    • Shuyao Hua
    • Min Fang

    Research 01 December 2022 Pages: 2167 - 2179

    

29. Superoxide dismutase 2 as a predictor in patients with hepatitis B virus-associated acute-on-chronic liver failure

    • Huihui Liu
    • Hui Lyu
    • Kai Wang

    Research 04 January 2023 Pages: 2181 - 2192

    

30. The influence of stimulated thyroglobulin and lymphocyte subsets before radioiodine therapy on the therapeutic response in patients with intermediate- and high-risk papillary thyroid carcinoma

    • Chenghui Lu
    • Congcong Wang
    • Xufu Wang

    Original Article 08 November 2022 Pages: 2193 - 2200

    

31. Relationship of age and gender with cytopathological findings of thyroid nodules diagnosed by FNAC: a retrospective study

    • Haider Ali Malakzai
    • Abdul Latif Khairy
    • Jamshid Abdul-Ghafar

    Original Article 16 October 2022 Pages: 2201 - 2207

    

32. Cancer-associated fibroblasts in papillary thyroid carcinoma

    • Li Zhu
    • Xuemei Zhang
    • Zhaowei Meng

    Research 30 January 2023 Pages: 2209 - 2220

    

33. The impact of cancer on the severity of disease in patients affected with COVID-19: an umbrella review and meta-meta-analysis of systematic reviews and meta-analyses involving 1,064,476 participants

    • Mehmet Emin Arayici
    • Yasemin Basbinar
    • Hulya Ellidokuz

    Original Article 07 October 2022 Pages: 2221 - 2229

    

34. Use of remdesivir for COVID-19 in patients with hematologic cancer

    • Alexandra Martin-Onraët
    • Corazón Barrientos-Flores
    • Pamela Alatorre-Fernandez

    Research 12 December 2022 Pages: 2231 - 2238

35. Association of body mass index with COVID-19-related neurologic sequelae: a retrospective cohort study

    • Sameer Elsayed
    • Ana Cabrera
    • William Hanage

    Research 16 December 2022 Pages: 2239 - 2251

    

36. Correction to: Association of body mass index with COVID‑19‑related neurologic sequelae: a retrospective cohort study

    • Sameer Elsayed
    • Ana Cabrera
    • William Hanage

    Correction 09 February 2023 Pages: 2253 - 2254

    

37. Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients

    • Jeongjae Lee
    • A Reum Kim
    • Sung-Han Kim

    Research 06 January 2023 Pages: 2255 - 2264

    

38. Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients

    • Jeongjae Lee
    • A Reum Kim
    • Sung-Han Kim

    Correction 06 February 2023 Pages: 2265 - 2265

39. Comparison of immune response to SARS-COV-2 vaccine in COVID-recovered versus non-infected Individuals

    • Saadiya Mushtaq
    • Muhammad Khalid Azam Khan
    • Biaoyang Lin

    Research 21 February 2023 Pages: 2267 - 2273

    

40. Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study

    • Alessandra Oliva
    • Francesco Cogliati Dezza
    • Claudio Maria Mastroianni

    Research Open access 03 March 2023 Pages: 2275 - 2285

    

41. The top 100 most cited articles on COVID-19 vaccine: a bibliometric analysis

    • Weigang Wang
    • Hu Wang
    • Suping Wang

    Research 20 March 2023 Pages: 2287 - 2299

    

42. Age is a major determinant for poor prognosis in patients with pilocytic astrocytoma: a SEER population study

    • Yusuke Tomita
    • Elizabeth A. Hibler
    • Yoshihiro Otani

    Original Article 05 September 2022 Pages: 2301 - 2309

    

43. DHA inhibits invasion and metastasis in NSCLC cells by interfering with CCL18/STAT3 signaling pathway

    • Hai-qing Luo
    • Yu-meng Huang
    • Xiang-yong Li

    Original Article Open access 10 October 2022 Pages: 2311 - 2320

    

44. Clinical spectrum of Chinese hospitalized lung cancer patients with concomitant interstitial lung disease: before and after the new era of LC treatment

    • Ruxuan Chen
    • Chi Shao
    • Zuojun Xu

    Research Open access 30 January 2023 Pages: 2321 - 2330

    

45. Value of peripheral blood circulating tumor cell detection in the diagnosis of thoracic diseases and the prediction of severity

    • Chang Qi
    • Xian-Zhi Xiong

    Research Open access 16 March 2023 Pages: 2331 - 2339

    

46. Mammography diagnosis of breast cancer screening through machine learning: a systematic review and meta-analysis

    • Junjie Liu
    • Jiangjie Lei
    • Mingwang Shen

    Original Article 15 October 2022 Pages: 2341 - 2356

    

47. Improving the malignancy prediction of breast cancer based on the integration of radiomics features from dual-view mammography and clinical parameters

    • Chenyi Zhou
    • Hui Xie
    • Yanling Wang

    Original Article 21 November 2022 Pages: 2357 - 2368

    

48. Predictive significance of HIF-1α, Snail, and PD-L1 expression in breast cancer

    • Evgenia Zubareva
    • Marina Senchukova
    • Tatyana Karmakova

    Research 21 February 2023 Pages: 2369 - 2383

    

49. Evaluation of Forkhead BOX M1 (FOXM1) gene expression in colorectal cancer

    • Tahseen Bilal Rather
    • Ishrat Parveiz
    • Syed Mudassar

    Original Article 01 November 2022 Pages: 2385 - 2405

    

50. Correction to: Evaluation of Forkhead BOX M1 (FOXM1) gene expression in colorectal cancer

    • Tahseen Bilal Rather
    • Ishrat Parveiz
    • Syed Mudassar

    Correction 20 December 2022 Pages: 2407 - 2407